Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70260 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Berrak Ertugrul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Sciences, Ataturk University, Erzurum, Türkiye. Hauptthemen laut MEDLINE: Tamoxifen, Drug Design, Breast Neoplasms, Antineoplastic Agents, Hormonal. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye (TÜBİTAK, Project No. 121Z116).
Abstract (Originalsprache)
Tamoxifen (TMX) resistance presents a significant challenge in the treatment of ER+ breast cancer. In this study, four novel tamoxifen‐based dimers were synthesized and evaluated for their antitumor activities. Among these, ( Z,Z )‐ 1 exhibited potent antiproliferative effects in ER+ cells, demonstrating selective toxicity toward cancer cells over normal cells. ( Z,Z )‐ 1 significantly outperformed tamoxifen with IC 50 values of 9.18 μM (24 h) and 6.86 μM (48 h) against MCF‐7 cells. Additionally, it showed greater selectivity toward ER+ breast cancer cells compared with both triple‐negative cancer cells and non‐cancerous cells. Mechanistic studies indicated that ( Z,Z )‐ 1 induces apoptosis in MCF‐7 cells through a cell‐cycle‐independent mechanism, unlike TMX, which arrests cells at the G0/G1 phase. These findings suggest that ( Z,Z )‐ 1 may be a promising candidate for further development as an alternative to tamoxifen therapy in ER+ breast cancer treatment. The docking studies revealed that ( Z,Z )‐ 1 exhibits the strong binding affinity to ERα, highlighting its potential as a promising therapeutic candidate for ER+ breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Sciences, Ataturk University, Erzurum, Türkiye.
- Department of Molecular Biology and Genetics, Erzurum Technical University, Erzurum, Türkiye.
- Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Türkiye.
- Department of Medical Services and Techniques, Vocational School of Health Services, Hakkari University, Hakkari, Türkiye.
- Department of Analytical Chemistry, Faculty of Pharmacy, Kocaeli Health and Technology University, Kocaeli, Türkiye.
- Biotechnology Institute, Ankara University, Ankara, Türkiye.
ORCID-Profile: Nurullah Saracoglu
Förderung
- The Scientific and Technological Research Council of Türkiye (TÜBİTAK, Project No. 121Z116)
Zitieren
APA
Ertugrul, B., Aytatli, A., Karatas, O. F., Essiz, S., Aksakal, F., & Saracoglu, N. (2026). Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70260
Vancouver
Ertugrul B, Aytatli A, Karatas OF, Essiz S, Aksakal F, Saracoglu N. Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70260
BibTeX
@article{Ertugrul2026,
author = {Ertugrul, Berrak and Aytatli, Abdulmelik and Karatas, Omer Faruk and Essiz, Selcuk and Aksakal, Fatma and Saracoglu, Nurullah},
title = {Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70260}
}
EUVIMED